Author Question: In utilizing the collected information about the patient's conditions before giving medications, the ... (Read 37 times)

LCritchfi

  • Hero Member
  • *****
  • Posts: 519
In utilizing the collected information about the patient's conditions before giving medications, the LPN/LVN is engaged in which step of medication planning?
 
  1. The color of the medication in pill form.
  2. Only the nurse can administer this medication.
  3. Other drugs that do not affect medication's route.
  4. The reason and goal of the medications given.

Question 2

Hormones may be prescribed for a patient with cancer of the:
 
  1. bone.
  2. prostate.
  3. brain.
  4. liver.



Juro

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

4
In planning to give a medication, the LPN/LVN must understand the reason or goal for each me-dication to be given, that is, what is this drug supposed to do for the patient?

Answer to Question 2

2
Some tumors, such as cancer of the prostate, may depend on male or female hormones, the chemicals produced by the sex glands.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library